Drug Patent Watch

OCTOBER 28, 2024

The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to streamline the drug development and manufacturing process. Here are the top 10 CDMO services you might not have known you needed… Source

Pharmaceutical Companies

Drug Patent Watch

JANUARY 14, 2025

.”[2] This study not only addressed the ATA’s concerns but also highlighted the power of real-world evidence in generic drug development and regulation. Case Study 3: Modeling the Future of Generic Drugs Who says you need a crystal ball to predict the future?

Drug Development

Drug Patent Watch

DECEMBER 10, 2024

They can help ensure that these submissions are complete, accurate, and timely, which is critical for advancing drug development programs. They can help ensure that the commercial pharmaceutical manufacturing process is designed to meet regulatory requirements and offer insight into the most effective manufacturing strategies.

Documentation

Drug Patent Watch

DECEMBER 9, 2024

This approach has led to the discovery of numerous potential drug candidates. From Lab to Market: The Long Road of Drug Development Once a promising compound is identified, it enters the long and costly process of drug development. Q: How long does a drug patent last?

Compounding

Express Pharma

MARCH 16, 2025

In India, pharmaceutical companies responded to global environmental concerns and government mandates by adopting greener manufacturing techniques. First, advanced research and development (R&D) and biologics will be critical. This transition will require substantial investments in several key areas.

Biosimilars

Drug Patent Watch

APRIL 14, 2025

"Compliance in Generic Drug Development: A Critical Component of Success As the generic drug industry continues to grow, ensuring compliance with regulatory requirements has become a top priority for pharmaceutical companies.

Drug Development

STAT

DECEMBER 19, 2024

Access to cheaper alternatives and low enrollment prompted the company to remove the medicine — along with the HIV medicines Emtriva, Tybost, and Complera — from its patent assistance program next month, according to an Oct. 8 letter that announced the move and that has not been widely reported.

Pharmaceutical Companies

Express Pharma

DECEMBER 30, 2024

Universities serve as the foundational training ground for the next generation of pharmaceutical professionals. They offer various programs, from undergraduate degrees in pharmaceutical sciences to specialised graduate courses focusing on drug development, regulatory affairs, and market access.

Pharmaceutical Companies

Drug Patent Watch

FEBRUARY 13, 2025

The Unsung Heroes of Generic Drug Development: The Power of Partnerships As we navigate the complex landscape of pharmaceuticals, it's easy to overlook the crucial role that partnerships play in bringing affordable, life-saving medications to market. When it comes to developing generic drugs, partnerships can take many forms.

Drug Development

Express Pharma

JULY 8, 2025

Dr Mahesh Bhalgat, Group CEO and Managing Director, Veeda Clinical Research Limited, said, “Our partnership will transform Veeda into an AI-driven oncology drug development organisation, meeting the growing demand for diversity in clinical trials, which is in line with the expectations of regulators and pharmaceutical companies.

Pharmaceutical Companies

STAT

DECEMBER 6, 2024

The European Commission on Friday unconditionally approved a controversial deal in which Novo Holdings, the parent company of Novo Nordisk, one of the largest pharmaceutical companies, would pay $16.5 billion for Catalent, a leading contract drug manufacturer.

Pharmaceutical Companies

Drug Patent Watch

DECEMBER 18, 2024

This exclusivity is the lifeblood of pharmaceutical innovation, allowing companies to recoup their massive R&D investments and incentivizing further research. According to a 2021 study by the Tufts Center for the Study of Drug Development, the average cost to develop a new drug is a staggering $2.6

Drug Development

Express Pharma

AUGUST 5, 2025

The Society for Pharmaceutical Dissolution Science (SPDS) recently unveiled the commencement of its regional outreach with Disso Asia 2025 , a two-day international symposium held in Jakarta. Dr Rajeev Raghuvanshi, Drugs Controller General of India, delivered the keynote address.

Drug Development

Pharma Leaders

APRIL 3, 2025

This potential stems from accelerating drug discovery, streamlining development and approval processes, and optimizing marketing strategies—fundamentally reshaping the entire drug development lifecycle.

Communication

Express Pharma

APRIL 8, 2025

To address growing demand from the pharmaceutical industry, Asahi Kasei has launched a new division, Asahi Kasei Life Science, effective from 1 April 2025. The new structure is designed to unify its bioprocess businesses and streamline services offered to pharmaceutical partners across drug development and manufacturing.

Pharmaceutical Manufacturing

Express Pharma

JULY 15, 2025

The gathering brought together senior representatives from hospitals, pharmaceutical companies, policymakers, and ESG leaders, including Fortis, Apollo, Quadria Capital, and Tata Capital Healthcare Fund. The report was released at an event held in New Delhi, supported by Quadria Capital and HealthQuad.

Hospitals

Drug Patent Watch

DECEMBER 12, 2024

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies.

Pharmaceutical Companies

European Pharmaceutical Review

NOVEMBER 25, 2024

An increasing trend of outsourcing boosts growth of the market as pharmaceutical companies are utilising advanced testing capabilities and optimising their drug development processes. The market is furthermore expected to see a compound annual growth rate (CAGR) of 7.3 percent between 2024 and 2032.

Drug Development

Pharmaceutical Technology

JUNE 24, 2025

This rapid processing not only enhances throughput, but will also allow pharmaceutical companies to respond more swiftly to market demands. DMC’s innovative design incorporates an ultrathin conductive layer, typically made of gold, which enables the application of electrical fields across ionic and affinity membrane adsorbers.

Pharmaceutical Manufacturing

Pharmacy Times

JUNE 23, 2025

CMS is issuing unique J-codes for 505(b)(2) drugs, classifying them as sole-source products if not therapeutically equivalent. This pathway reduces submission denial risk, accelerates drug development, and offers potential market exclusivity for up to 7 years.

Pharmacy Technician

PharmaTech

JULY 25, 2025

full transcript below In Part 4 of our multi-part interview series, Jason Waite, an international trade expert at Alston & Bird, underscores the urgent need for pharmaceutical companies to build cross-functional trade compliance teams in response to rising global trade tensions—particularly potential Section 232 tariffs.

Dosage

Pharma Marketing Network

MAY 11, 2025

market still viable for Asian pharmaceutical companies? Companies need to offer differentiated value and prepare for increased competition and tighter pricing. They should diversify their geographic markets, invest in innovative drug development, and focus on outcomes-driven marketing. Is the U.S.

Drug Pricing

PharmExec

JULY 31, 2025

Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces.

Communication

PharmaTech

JULY 4, 2025

Challener News Article Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise. Pharmaceutical companies have responded with growing investment in the research and development of novel eye treatments and drug delivery systems designed to address key challenges in ocular therapy.

Dosage

PharmExec

AUGUST 8, 2025

Pharmaceutical companies face strategic business implications due to limited access, impacting R&D investment returns and market growth. Pharmaceutical companies are generally flexible in terms of pricing structures, provided such arrangements do not negatively impact broader market dynamics.

Communication

Pharmaceutical Technology

JULY 18, 2025

Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceutical company ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation.

Packaging

Pharma Leaders

JUNE 17, 2025

The pharmaceutical industry is facing unprecedented financial scrutiny, particularly with policies like the Trump Administration’s “Most Favored Nation” (MFN) pricing, which aims to lower drug costs in the US by aligning them with the lowest global prices.

Drug Development

Drug Patent Watch

DECEMBER 11, 2024

This growth has created a competitive landscape where pharmaceutical companies must carefully evaluate and select the right CDMO partner to ensure the success of their projects. Your Drugs Development Stage The stage of your drug development is a critical factor in selecting a CDMO.

Pharmaceutical Companies

Pharmaceutical Technology

JUNE 19, 2025

Both modalities have emerged as the most used platform technologies in developing oligonucleotide-based drugs for CNS disorders since 2020. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51 billion) of these deals.

Communication

pharmaphorum

JULY 24, 2025

Skip to main content Thursday 24 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Pharmaceutical Technology

JULY 16, 2025

The initiative comes at a crucial time, as British pharmaceutical companies are significantly increasing their investments in the United States. GSK invested $800m in drug substance and drug product manufacturing facilities in the US in October 2024.

Packaging

Viseven

JUNE 18, 2025

” How AI Will Revolutionize Medical Affairs Pharmaceutical companies are actively leveraging artificial intelligence and its capabilities, encouraging their medical affairs teams to make AI a critical part of their workflows.

Labelling

PharmExec

AUGUST 4, 2025

Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces.

Communication

European Pharmaceutical Review

JULY 9, 2025

It represents one of the highest-risk stages in sterile pharmaceutical manufacturing” The importance of fill and finish cannot be overstated. It represents one of the highest-risk stages in sterile pharmaceutical manufacturing, where even minute contamination can render entire batches unusable.

Pharmaceutical Manufacturing

PharmExec

AUGUST 1, 2025

drug prices to be as low as or lower than global prices, targeting 17 major pharmaceutical companies. The President's letters criticize companies for inadequate responses and propose specific steps to comply with the MFN order. innovation and investment in drug development, potentially ceding leadership to China.

Communication

Express Pharma

JANUARY 26, 2025

The meeting highlighted the enduring economic and commercial ties between the two nations, with a particular focus on pharmaceutical exports and collaboration in drug development, formulations, vaccines, and Active Pharmaceutical Ingredients (APIs).

Pharmaceutical Manufacturing

Pharmaceutical Technology

JULY 31, 2025

Q: How would you describe the recurring challenges of these industries, particularly with regards to developing and commercialising new advanced therapies? A: It takes quite a bit of cross-functional work to bring different members of the pharmaceutical drug development communities together.

Hospitals